BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37594318)

  • 1. Children living in extreme poverty face a greater risk of acute lymphoblastic leukemia relapse.
    Nierengarten MB
    Cancer; 2023 Sep; 129(18):2764. PubMed ID: 37594318
    [No Abstract]   [Full Text] [Related]  

  • 2. Poverty and relapse risk in children with acute lymphoblastic leukemia: a Children's Oncology Group study AALL03N1 report.
    Wadhwa A; Chen Y; Hageman L; Hoppmann A; Angiolillo A; Dickens DS; Neglia JP; Ravindranath Y; Ritchey AK; Termuhlen A; Wong FL; Landier W; Bhatia S
    Blood; 2023 Jul; 142(3):221-229. PubMed ID: 37070673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000-2010).
    Bona K; Blonquist TM; Neuberg DS; Silverman LB; Wolfe J
    Pediatr Blood Cancer; 2016 Jun; 63(6):1012-8. PubMed ID: 26913850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second relapse in childhood acute lymphoblastic leukemia: a call for action.
    Kulkarni KP; Marwaha RK
    Indian J Pediatr; 2011 Mar; 78(3):362-3. PubMed ID: 21046288
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating childhood acute lymphoblastic leukemia in a country with no pediatric hematologist/oncologist: a Belize/Mérida joint venture.
    Grant E; González-Montalvo P; Pantoja-Guillén F; Escamilla G
    Blood Adv; 2018 Nov; 2(Suppl 1):67-68. PubMed ID: 30504207
    [No Abstract]   [Full Text] [Related]  

  • 7. High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment.
    Heatley SL; Sadras T; Kok CH; Nievergall E; Quek K; Dang P; McClure B; Venn N; Moore S; Suttle J; Law T; Ng A; Muskovic W; Norris MD; Revesz T; Osborn M; Moore AS; Suppiah R; Fraser C; Alvaro F; Hughes TP; Mullighan CG; Marshall GM; Pozza LD; Yeung DT; Sutton R; White DL
    Haematologica; 2017 Dec; 102(12):e490-e493. PubMed ID: 28935844
    [No Abstract]   [Full Text] [Related]  

  • 8. Late relapsing childhood lymphoblastic leukemia.
    Vora A; Frost L; Goodeve A; Wilson G; Ireland RM; Lilleyman J; Eden T; Peake I; Richards S
    Blood; 1998 Oct; 92(7):2334-7. PubMed ID: 9746771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of body mass index on relapse in children with acute lymphoblastic leukemia treated according to Nordic treatment protocols.
    Egnell C; Ranta S; Banerjee J; Merker A; Niinimäki R; Lund B; Mogensen PR; Jonsson ÓG; Vaitkeviciene G; Lepik K; Forslund A; Heyman M; Harila-Saari A
    Eur J Haematol; 2020 Dec; 105(6):797-807. PubMed ID: 32909636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
    J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full donor chimerism by day 30 after allogeneic peripheral blood progenitor cell transplantation is associated with a low risk of relapse in pediatric patients with hematological malignancies.
    Lassaletta A; Ramírez M; Montero JM; González-Vicent M; Balas A; Madero L; Díaz MA
    Leukemia; 2005 Apr; 19(4):504-6. PubMed ID: 15729381
    [No Abstract]   [Full Text] [Related]  

  • 12. Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemia.
    Locatelli F; Eckert C; Hrusak O; Buldini B; Sartor M; Zugmaier G; Zeng Y; Pilankar D; Morris J; von Stackelberg A
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29715. PubMed ID: 35482538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse of acute lymphoblastic leukemia presenting as masquerade uveitis with hypopyon in a child.
    Rehman O; Das D; Magdalene D; Bhattacharjee K; Deka D; Singh S; Bhadani P
    Indian J Ophthalmol; 2022 Jul; 70(7):2732-2733. PubMed ID: 35791226
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypothalamic syndrome as an unusual presentation of CNS relapse of acute lymphoblastic leukemia in children: report of 4 cases].
    Mathey M; Guitter M; Rossi J; Latella A; Felice MS
    Arch Argent Pediatr; 2021 Jun; 119(3):e242-e246. PubMed ID: 34033430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How should childhood acute lymphoblastic leukemia relapses in low-income and middle-income countries be managed: The AHOPCA-ALL study group experience.
    Espinoza D; Blanco Lopez JG; Vasquez R; Fu L; Martínez R; Rodríguez H; Navarrete M; Howard SC; Friedrich P; Valsecchi MG; Conter V; Ceppi F
    Cancer; 2023 Mar; 129(5):771-779. PubMed ID: 36504077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype.
    Franca R; Rebora P; Athanasakis E; Favretto D; Verzegnassi F; Basso G; Tommasini A; Valsecchi MG; Decorti G; Rabusin M
    Pharmacogenomics; 2014 Apr; 15(5):619-27. PubMed ID: 24798719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Race/Ethnicity and Socioeconomic Status on Outcome in Childhood Acute Lymphoblastic Leukemia.
    Acharya S; Hsieh S; Shinohara ET; DeWees T; Frangoul H; Perkins SM
    J Pediatr Hematol Oncol; 2016 Jul; 38(5):350-4. PubMed ID: 27177145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the effect of 3 glucocorticoid receptor gene polymorphisms on risk of relapse in 100 Iranian children with acute lymphoblastic leukemia: a case-control study.
    Namazi S; Zareifar S; Monabati A; Ansari S; Karimzadeh I
    Clin Ther; 2011 Mar; 33(3):280-90. PubMed ID: 21497906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.